OcuSciences’ eye health diagnostic instrument gains EU CE clearance
October 16, 2025
The clearance led to the deployment of the instrument across various medical facilities in the UK and Europe.
The clearance led to the deployment of the instrument across various medical facilities in the UK and Europe.
A new international study led by researchers at Karolinska Institutet demonstrates that it is possible to detect subtle changes in the brain and identify early signs of hereditary frontotemporal dementia using advanced brain imaging techniques. The study is published in Molecular Psychiatry.
Two new research papers from the Living Brain Project at Mount Sinai present what is, by several metrics, the largest investigation ever performed of the biology of the living human brain. The papers present unequivocal evidence that brain tissue from living people has a distinct molecular character, an observation that until now was missed because brain tissue from living people is rarely studied.
SANTA MONICA, Calif. and NETANYA, Israel, Oct. 15, 2025 /PRNewswire/ — CAPS Medical, a clinical-stage MedTech company developing a platform for selective tumor ablation across multiple indications, today announced that its PlasmaSure™ System has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the treatment of low- to intermediate-risk non-muscle invasive bladder cancer (NMIBC). The PlasmaSure™ platform delivers non-thermal atmospheric plasma energy through the working channels of standard minimally invasive tools, in the case of NMIBC, through cystoscopes, enabling highly selective, tissue-preserving tumor ablation.
Florida Atlantic University has expanded its NeuroInnovate Center, becoming the first institution globally to integrate advanced MRI and focused ultrasound technologies into a single, unified platform for both preclinical and clinical research. This breakthrough will accelerate the development of non-invasive treatments for neurological disorders such as Alzheimer’s, Parkinson’s and more.
When doctors analyze a medical scan of an organ or area in the body, each part of the image has to be assigned an anatomical label. If the brain is under scrutiny, for instance, its different parts have to be labeled as such, pixel by pixel: cerebral cortex, brain stem, cerebellum, etc. The process, called medical image segmentation, guides diagnosis, surgery planning and research.
Uncontrolled bleeding during surgery remains one of the deadliest medical emergencies. Injuries to internal organs such as the liver or spleen are especially dangerous because bleeding is difficult to control and often life-threatening.
A friend’s struggles with arthritis and the finger braces used to manage it inspired research by a Carnegie Mellon University student that could make it easier for patients to follow rehabilitation plans, speed up recovery times and help people manage chronic conditions.
For the first time, scientists can freeze-frame the exact moment an animal makes up their mind and commits to a choice—simply by looking at their brain activity.
Researchers at the University of California, Irvine have developed a 3D human colon model integrated with bioelectronics to aid in colorectal cancer research and drug discovery. The “3D in vivo mimicking human colon” enables precision, personalized medicine and offers a more ethical, accurate and cost-effective alternative to traditional animal testing.